Consolidated Statement Of Comprehensive Income

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7572450

Concept 2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
JPY
214,733,000,000 JPY
214,733,000,000 JPY
JPY
JPY
JPY
214,733,000,000 JPY
JPY
JPY
157,560,000,000 JPY
157,560,000,000 JPY
JPY
157,560,000,000 JPY
JPY
Other comprehensive income
Items that will not be reclassified to profit or loss
Remeasurements of defined benefit plans
3,630,000,000 JPY
329,000,000 JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income
-22,000,000 JPY
-255,000,000 JPY
Total of items that will not be reclassified to profit or loss
3,608,000,000 JPY
74,000,000 JPY
Items that may be reclassified to profit or loss
Exchange differences on translation of foreign operations
1,467,000,000 JPY
-1,172,000,000 JPY
Effective portion of cash flow hedges
-3,072,000,000 JPY
-1,317,000,000 JPY
Total of items that may be reclassified to profit or loss
-1,593,000,000 JPY
-2,506,000,000 JPY
Other comprehensive income
2,015,000,000 JPY
-2,433,000,000 JPY
Comprehensive income
JPY
216,748,000,000 JPY
218,363,000,000 JPY
-1,615,000,000 JPY
JPY
JPY
216,748,000,000 JPY
JPY
JPY
157,889,000,000 JPY
155,127,000,000 JPY
JPY
155,127,000,000 JPY
-2,761,000,000 JPY
Comprehensive income attributable to
Owners of parent
216,748,000,000 JPY
155,127,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.